Aztreonam
آزترئونام
🦠 Antiinfectives For Systemic UseMonobactam
Market / country: 🇺🇸 USA
Azactam (US)
🧮 Dose calculator
Urinary tract infection · Regimen source: FDA Azactam · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to aztreonam. FDA Azactam · Contraindications
Warnings
- • Serious hypersensitivity; Clostridioides difficile-associated diarrhoea. FDA Azactam · Warnings
Formulations
- 1 g vial — powder for injection 🇺🇸 USA FDA Azactam · How Supplied
- 2 g vial — powder for injection 🇺🇸 USA FDA Azactam · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Azactam · Pregnancy
“Because animal reproduction studies are not always predictive of human response, aztreonam should be used during pregnancy only if clearly needed.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Azactam · Nursing Mothers
“Aztreonam is excreted in human milk in concentrations that are less than 1% of concentrations determined in simultaneously obtained maternal serum; consideration should be given to temporary discontinuation of nursing and use of formula feedings.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Azactam · Pediatric Use
“The safety and effectiveness of intravenous AZACTAM have been established in the age groups 9 months to 16 years.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Azactam · Geriatric Use
“In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA050580
- DailyMed (FDA label)FDA Azactam
- MedlinePlus (NIH)Aztreonam Injection
- WHO ATC/DDDJ01DF01
- Darooyab (Iran)Aztreonam
🇮🇷 Not found in Iran list Darooyab · G-288/Aztreonam
Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Azactam · How SuppliedFDA Azactam · Dosage and AdministrationFDA Azactam · WarningsFDA Azactam · ContraindicationsFDA Azactam · PregnancyFDA Azactam · Nursing MothersFDA Azactam · Pediatric UseFDA Azactam · Geriatric UseFDA Azactam · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-288/Aztreonam
- Clinical review⚠ Unverified